Market Overview:
The Global Dimetridazole (DMZ) Market is expected to grow at a CAGR of XX% and reach a market value of USD XX million by 2030. The market is segmented on the basis of type, purity, application and region. On the basis of type, the market is segmented into Purity ≥98% and Purity ≥99.5%. On the basis of purity, the market is further divided into Animal Drugs and Feed Additives. The feed additives segment dominated in 2017 with a share of XX%.
Product Definition:
Dimetridazole (DMZ) is a water soluble, white powder that is used as a drug to treat parasitic infections in both humans and animals. It works by inhibiting the synthesis of DNA and RNA in parasites, which prevents them from growing or reproducing.
Purity ≥98%:
Purity more than 98% is a special kind of purification process which is used to separate the impurities from the desired substance. Purity percentage refers to the amount of pure compound remaining in a product after passing through various purification steps under defined conditions.
The DMZ market purity percentage trend has been witnessing significant growth over recent years and this trend is expected to continue over the forecast period owing to its increasing demand as an anti-cancer drug.
Purity ≥99.5%:
Purity 99.5% or P95 is a special grade of acetic acid used in the production of DMZ, which is an important intermediate for chemicals and pharmaceuticals. It has no substitute and can be found in very few quantities on earth as its synthesis requires extremely rare elements such as yttrium, platinum, rhodium & iridium along with other heavy metals that are extracted from deep underground mines.
The global purity ≥99.
Application Insights:
Animal drugs application led the global dimetridazole (DMZ) market in 2017, followed by feed additives. The animal drugs segment is expected to maintain its dominance over the forecast period due to high product usage in veterinary medicines globally. Increasing pet ownership and livestock production are likely to boost demand for animal healthcare globally, thereby augmenting the growth of this market during the estimated time period.
Feed additives segment is also projected to witness significant growth over next six years owing to rising consumer awareness regarding proper nutrition and health of animals coupled with increasing use of feed additives that improve animal productivity worldwide. In addition, stringent government regulations on maximum permissible levels of pesticides in food crops are further anticipated to propel demand for feed additive products containing DMZ worldwide which will benefit industry expansion during future phases as well.
Regional Analysis:
Asia Pacific is expected to be the fastest-growing region over the forecast period. The growth of this region can be attributed to increasing meat consumption in China and India. Asia Pacific was followed by North America, which accounted for a market share of over 25% in 2017 owing to high animal feed production coupled with rising demand for pet food products. Europe also held a significant share due to stringent regulations by governing bodies such as EMEA and FDA regarding quality standards associated with veterinary drugs and feed additives.
The Middle East & Africa (MEA) is anticipated to grow at an exponential rate during the forecast period owing to rapid development coupled with increasing per capita income among people living in countries, such as Saudi Arabia, UAE, Egypt & Iran; these factors are expected drive product demand from 2018 through 2030 (estimated).
Growth Factors:
- Increasing demand for food animal products due to population growth and rising income levels in emerging countries
- Growing awareness about the benefits of using DMZ as a feed additive among livestock producers
- Rising demand for organic meat and poultry products, which can be achieved through the use of DMZ as a feed additive
- Technological advancements that have made it possible to produce more meat with fewer animals, thereby driving demand for DMZ as a feed additive
- Stringent regulations on antibiotic use in livestock production that are encouraging the adoption of DMZ as an alternative to antibiotics
Scope Of The Report
Report Attributes
Report Details
Report Title
Dimetridazole (DMZ) Market Research Report
By Type
Purity ≥98%, Purity ≥99.5%
By Application
Animal Drugs, Feed Additives
By Companies
Boehringer Ingelheim, China Animal Husbandry Industry (CAHIC), Masteam Bio-tech, Hubei Qida, Boehringer Ingelheim
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
209
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Dimetridazole (DMZ) Market Report Segments:
The global Dimetridazole (DMZ) market is segmented on the basis of:
Types
Purity ≥98%, Purity ≥99.5%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Animal Drugs, Feed Additives
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim
- China Animal Husbandry Industry (CAHIC)
- Masteam Bio-tech
- Hubei Qida
- Boehringer Ingelheim
Highlights of The Dimetridazole (DMZ) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity ≥98%
- Purity ≥99.5%
- By Application:
- Animal Drugs
- Feed Additives
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dimetridazole (DMZ) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dimetridazole is a medication used to treat fungal infections. It works by killing the fungus. Dimetridazole is usually taken by mouth, but it can also be given as an injection into a vein.
Some of the major companies in the dimetridazole (dmz) market are Boehringer Ingelheim, China Animal Husbandry Industry (CAHIC), Masteam Bio-tech, Hubei Qida, Boehringer Ingelheim.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dimetridazole (DMZ) Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Dimetridazole (DMZ) Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Dimetridazole (DMZ) Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Dimetridazole (DMZ) Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Dimetridazole (DMZ) Market Size & Forecast, 2018-2028 4.5.1 Dimetridazole (DMZ) Market Size and Y-o-Y Growth 4.5.2 Dimetridazole (DMZ) Market Absolute $ Opportunity
Chapter 5 Global Dimetridazole (DMZ) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Dimetridazole (DMZ) Market Size Forecast by Type
5.2.1 Purity ≥98%
5.2.2 Purity ≥99.5%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Dimetridazole (DMZ) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Dimetridazole (DMZ) Market Size Forecast by Applications
6.2.1 Animal Drugs
6.2.2 Feed Additives
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dimetridazole (DMZ) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dimetridazole (DMZ) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Dimetridazole (DMZ) Analysis and Forecast
9.1 Introduction
9.2 North America Dimetridazole (DMZ) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Dimetridazole (DMZ) Market Size Forecast by Type
9.6.1 Purity ≥98%
9.6.2 Purity ≥99.5%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Dimetridazole (DMZ) Market Size Forecast by Applications
9.10.1 Animal Drugs
9.10.2 Feed Additives
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Dimetridazole (DMZ) Analysis and Forecast
10.1 Introduction
10.2 Europe Dimetridazole (DMZ) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Dimetridazole (DMZ) Market Size Forecast by Type
10.6.1 Purity ≥98%
10.6.2 Purity ≥99.5%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Dimetridazole (DMZ) Market Size Forecast by Applications
10.10.1 Animal Drugs
10.10.2 Feed Additives
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Dimetridazole (DMZ) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Dimetridazole (DMZ) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Dimetridazole (DMZ) Market Size Forecast by Type
11.6.1 Purity ≥98%
11.6.2 Purity ≥99.5%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Dimetridazole (DMZ) Market Size Forecast by Applications
11.10.1 Animal Drugs
11.10.2 Feed Additives
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Dimetridazole (DMZ) Analysis and Forecast
12.1 Introduction
12.2 Latin America Dimetridazole (DMZ) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Dimetridazole (DMZ) Market Size Forecast by Type
12.6.1 Purity ≥98%
12.6.2 Purity ≥99.5%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Dimetridazole (DMZ) Market Size Forecast by Applications
12.10.1 Animal Drugs
12.10.2 Feed Additives
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Dimetridazole (DMZ) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Dimetridazole (DMZ) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Dimetridazole (DMZ) Market Size Forecast by Type
13.6.1 Purity ≥98%
13.6.2 Purity ≥99.5%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Dimetridazole (DMZ) Market Size Forecast by Applications
13.10.1 Animal Drugs
13.10.2 Feed Additives
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dimetridazole (DMZ) Market: Competitive Dashboard
14.2 Global Dimetridazole (DMZ) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boehringer Ingelheim
14.3.2 China Animal Husbandry Industry (CAHIC)
14.3.3 Masteam Bio-tech
14.3.4 Hubei Qida
14.3.5 Boehringer Ingelheim